Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program
Go back to Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 245.29 +4.81 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.48 | 52 Week High | $160.00 | |||
| Open | $244.60 | 52 Week Low | $95.80 | |||
| Day High | $246.57 | P/E | 45.59 | |||
| Day Low | $244.17 | EPS | $5.38 | |||
| Volume | 102,496 | |||||
